Merck & Co Inc
NYSE: MRK
$115.19
+$0.23 (+0.2%)
Real Time Data Delayed 15 Min.
MRK Articles
Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today. The company gave an update on an FDA clinical hold on its investigational vaccine...
Published:
Last Updated:
A lot of people believe that Merck (MRK) knew a lot more about the dangers of its arthritis drug Vioxx than the company ever let on. Heart problems were apparently a by-product of using the...
Published:
Last Updated:
According to Reuters, the Treasury will make $250 billion directly into banks. Ciitgroup (C) and JPMorgan (JPM) would get $26 billion each. Merrill Lynch (MER) and Bank of America (BAC) would each...
Published:
Last Updated:
Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading up on a very weak trading day after what many had deemed as a fishy merger...
Published:
Last Updated:
According to Reuters, the House will vote on the bailout bill today. Reuters reports that JP Morgan (JPM) will not keep the CEO of WaMu. Reuters reports that John Thain of Merrill Lynch (MER) will...
Published:
Last Updated:
You know it’s a rough day in the market when even defensive stocks are weak or mixed. We are at least seeing a mixed bag from some of these. But the trend is a pretty easy one to see. Even...
Published:
According to Reuters, Lehman (LEH) will release earnings a week early after its stock dropped 45%. Reuters reports that OPEC agreed to a surprise production cut. Reuters reports that CFOs are more...
Published:
Last Updated:
The evidence that sales at many companies are struggling and that employment will suffer are almost everywhere. Recently, a division of GMAC said it would let 5,000 people go. According to MSNBC,...
Published:
Last Updated:
Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug Zetia. Another is a related drug called Vytorin. The sales of the treatments topped...
Published:
Last Updated:
Texas Instruments (TXN) Bad earnings take chip company down. Falls to $23.28 from 52-week high of $38.79. AMD (AMD) Chip company may have changed CEOs but Wall St. still thinks company is dead. Sells...
Published:
Last Updated:
According to Reuters, Apple (AAPL) missed Wall St. expectations, sending the stock down by 10%. Reuters reports that American Express (AXP) profits fell on credit losses. “The Next NVIDIA” Could...
Published:
Last Updated:
Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface. The problem is that the surface is about the only thing that looked appealing for the drug giant today. Merck...
Published:
Last Updated:
These are not all of the upgrades or positive analyst calls seen this morning but these are some of the top calls seen this Friday morning: Aventine Renewable (NYSE: AVR) Raised to Buy from Neutral...
Published:
According to Reuters, Robert Steel was named the new CEO of Wachovia (WB) and the bank said it would have a quarter loss of $2.6 to $2.8 billion. Reuters writes that the Blue Chip Economic Indicators...
Published:
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red rice yeast in...
Published: